Key facts
- Archimedes Vascular’s last known valuation is $8.0M (Jun 2025).
- It has raised $2.2M; the latest was Early Stage VC ($2.2M) in Jun 2025.
- Notable investors include Sherpa Healthcare Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Archimedes Vascular
- ·The full record, as it builds
Funding rounds
No funding rounds for Archimedes Vascular are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Archimedes Vascular
Operator of a medical device company intended to treat patients with severe hypertension. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Birmingham, AL, United States
- Ownership
- Privately Held (backing)
Archimedes Vascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Archimedes Vascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Archimedes Vascular in its N-PORT filings yet. We sweep new filings monthly.